Compare $MNPR vs $ZURA | Chartloom

Compare

$MNPR vs $ZURA

Monopar Therapeutics Inc · Zura Bio Ltd

MNPR

Monopar Therapeutics Inc

ZURA

Zura Bio Ltd

Compare $MNPR vs $ZURA

Comparing Monopar Therapeutics Inc and Zura Bio Ltd

MNPRMonopar Therapeutics Inc

ZURAZura Bio Ltd

MNPRMonopar Therapeutics Inc

Market cap

$529M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

48.37x

Rev growth (TTM)

—

YTD performance

19.6%

52W performance

-19.9%

FCF yield

-2.3%

ZURAZura Bio Ltd

Market cap

$380M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-27.9%

52W performance

-7.8%

FCF yield

-20.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MNPR

ZURA

Detailed metrics comparison

MNPR

Monopar Therapeutics Inc

ZURA

Zura Bio Ltd

Market Cap

MNPR$529M

ZURA$380M

Enterprise Value

MNPR$476M

ZURA$175M

Price

MNPR$78.96

ZURA$4.00

P/E Ratio

MNPRN/A

ZURAN/A

P/S Ratio

MNPR0.00x

ZURA0.00x

EV/Sales

MNPR0.00x

ZURA0.00x

EV/EBITDA

MNPR0.00x

ZURA0.00x

P/B Ratio

MNPR4.00x

ZURA1.98x

P/FCF Ratio

MNPRN/A

ZURAN/A

EV/FCF

MNPR-39.10x

ZURA-2.25x

PEG Ratio

MNPRN/A

ZURAN/A

Forward P/E (NTM)

MNPRN/A

ZURAN/A

Forward P/S (NTM)

MNPR48.37x

ZURAN/A

Revenue (TTM)

MNPR$0

ZURA$0

Revenue Growth (YoY)

MNPRN/A

ZURAN/A

Forward Rev Growth

MNPR327.6%

ZURA133.3%

Gross Margin (TTM)

MNPR0.0%

ZURA0.0%

Operating Margin (TTM)

MNPR0.0%

ZURA0.0%

EBITDA Margin (TTM)

MNPR0.0%

ZURA0.0%

Net Margin (TTM)

MNPR0.0%

ZURA0.0%

FCF Margin (TTM)

MNPRN/A

ZURAN/A

Net Income (TTM)

MNPR$-18M

ZURA$-116M

FCF (TTM)

MNPR$-12M

ZURA$-78M

EPS (TTM)

MNPR-$2.09

ZURA-$0.92

ROE (TTM)

MNPR-1308.0%

ZURA-5445.0%

ROA (TTM)

MNPR-1279.0%

ZURA-4853.0%

ROIC (TTM)

MNPR-1308.0%

ZURA-5445.0%

Cash

MNPR$53M

ZURA$205M

Debt

MNPR$0

ZURA$0

Net Cash/Debt

MNPR$53M

ZURA$205M

Current Ratio (TTM)

MNPR33.56x

ZURA12.90x

Quick Ratio (TTM)

MNPR33.56x

ZURA12.57x

Debt/Equity (TTM)

MNPR0.00x

ZURA0.00x

Debt/Assets (TTM)

MNPR0.0%

ZURA0.0%

Interest Coverage (TTM)

MNPRN/A

ZURAN/A

Net Debt/EBITDA (TTM)

MNPR0.00x

ZURA0.00x

Beta

MNPR1.54

ZURA-0.03

52W Performance

MNPR-19.9%

ZURA-7.8%

YTD Performance

MNPR19.6%

ZURA-27.9%

% from 52W High

MNPR-36.7%

ZURA-46.2%

% from 52W Low

MNPR57.7%

ZURA27.0%

Asset Turnover (TTM)

MNPR0.00x

ZURA0.00x

FCF Yield (TTM)

MNPR-2.3%

ZURA-20.4%

Earnings Yield (TTM)

MNPR-3.4%

ZURA-30.6%

Dividend Yield (TTM)

MNPRN/A

ZURAN/A

Rule of 40

MNPR0.0

ZURA0.0

EV/GP/RG

MNPRN/A

ZURAN/A

Ticker research

View MNPR research View ZURA research

Metric	MNPR Monopar Therapeutics Inc	ZURA Zura Bio Ltd
Market & Valuation
Market Cap	$529M	$380M
Enterprise Value	$476M	$175M
Price	$78.96	$4.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.00x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-39.10x	-2.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	48.37x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	327.6%	133.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-116M
FCF (TTM)	$-12M	$-78M
EPS (TTM)	-$2.09	-$0.92
ROE (TTM)	-1308.0%	-5445.0%
ROA (TTM)	-1279.0%	-4853.0%
ROIC (TTM)	-1308.0%	-5445.0%
Financial Health
Cash	$53M	$205M
Debt	$0	$0
Net Cash/Debt	$53M	$205M
Current Ratio (TTM)	33.56x	12.90x
Quick Ratio (TTM)	33.56x	12.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	-0.03
52W Performance	-19.9%	-7.8%
YTD Performance	19.6%	-27.9%
% from 52W High	-36.7%	-46.2%
% from 52W Low	57.7%	27.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-2.3%	-20.4%
Earnings Yield (TTM)	-3.4%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MNPR research	View ZURA research

Valuation

P/S Ratio

MNPR

0.00x

ZURA

0.00x

EV/FCF

MNPR

-39.10x

ZURA

-2.25x

Growth & revenue

Forward Revenue Growth

MNPR

327.6%

ZURA

133.3%

Profitability & performance

Gross Margin

MNPR

0.0%

ZURA

0.0%

ROE

MNPR

-1308.0%

ZURA

-5445.0%

FCF Yield %

MNPR

-2.3%

ZURA

-20.4%

52-Week Performance

ZURA

-7.8%

MNPR

-19.9%

Detailed metrics comparison

MNPR

Monopar Therapeutics Inc

ZURA

Zura Bio Ltd

Market Cap

MNPR$529M

ZURA$380M

Enterprise Value

MNPR$476M

ZURA$175M

Price

MNPR$78.96

ZURA$4.00

P/E Ratio

MNPRN/A

ZURAN/A

P/S Ratio

MNPR0.00x

ZURA0.00x

EV/Sales

MNPR0.00x

ZURA0.00x

EV/EBITDA

MNPR0.00x

ZURA0.00x

P/B Ratio

MNPR4.00x

ZURA1.98x

P/FCF Ratio

MNPRN/A

ZURAN/A

EV/FCF

MNPR-39.10x

ZURA-2.25x

PEG Ratio

MNPRN/A

ZURAN/A

Forward P/E (NTM)

MNPRN/A

ZURAN/A

Forward P/S (NTM)

MNPR48.37x

ZURAN/A

Revenue (TTM)

MNPR$0

ZURA$0

Revenue Growth (YoY)

MNPRN/A

ZURAN/A

Forward Rev Growth

MNPR327.6%

ZURA133.3%

Gross Margin (TTM)

MNPR0.0%

ZURA0.0%

Operating Margin (TTM)

MNPR0.0%

ZURA0.0%

EBITDA Margin (TTM)

MNPR0.0%

ZURA0.0%

Net Margin (TTM)

MNPR0.0%

ZURA0.0%

FCF Margin (TTM)

MNPRN/A

ZURAN/A

Net Income (TTM)

MNPR$-18M

ZURA$-116M

FCF (TTM)

MNPR$-12M

ZURA$-78M

EPS (TTM)

MNPR-$2.09

ZURA-$0.92

ROE (TTM)

MNPR-1308.0%

ZURA-5445.0%

ROA (TTM)

MNPR-1279.0%

ZURA-4853.0%

ROIC (TTM)

MNPR-1308.0%

ZURA-5445.0%

Cash

MNPR$53M

ZURA$205M

Debt

MNPR$0

ZURA$0

Net Cash/Debt

MNPR$53M

ZURA$205M

Current Ratio (TTM)

MNPR33.56x

ZURA12.90x

Quick Ratio (TTM)

MNPR33.56x

ZURA12.57x

Debt/Equity (TTM)

MNPR0.00x

ZURA0.00x

Debt/Assets (TTM)

MNPR0.0%

ZURA0.0%

Interest Coverage (TTM)

MNPRN/A

ZURAN/A

Net Debt/EBITDA (TTM)

MNPR0.00x

ZURA0.00x

Beta

MNPR1.54

ZURA-0.03

52W Performance

MNPR-19.9%

ZURA-7.8%

YTD Performance

MNPR19.6%

ZURA-27.9%

% from 52W High

MNPR-36.7%

ZURA-46.2%

% from 52W Low

MNPR57.7%

ZURA27.0%

Asset Turnover (TTM)

MNPR0.00x

ZURA0.00x

FCF Yield (TTM)

MNPR-2.3%

ZURA-20.4%

Earnings Yield (TTM)

MNPR-3.4%

ZURA-30.6%

Dividend Yield (TTM)

MNPRN/A

ZURAN/A

Rule of 40

MNPR0.0

ZURA0.0

EV/GP/RG

MNPRN/A

ZURAN/A

Ticker research

View MNPR research View ZURA research

Metric	MNPR Monopar Therapeutics Inc	ZURA Zura Bio Ltd
Market & Valuation
Market Cap	$529M	$380M
Enterprise Value	$476M	$175M
Price	$78.96	$4.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.00x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-39.10x	-2.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	48.37x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	327.6%	133.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-116M
FCF (TTM)	$-12M	$-78M
EPS (TTM)	-$2.09	-$0.92
ROE (TTM)	-1308.0%	-5445.0%
ROA (TTM)	-1279.0%	-4853.0%
ROIC (TTM)	-1308.0%	-5445.0%
Financial Health
Cash	$53M	$205M
Debt	$0	$0
Net Cash/Debt	$53M	$205M
Current Ratio (TTM)	33.56x	12.90x
Quick Ratio (TTM)	33.56x	12.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	-0.03
52W Performance	-19.9%	-7.8%
YTD Performance	19.6%	-27.9%
% from 52W High	-36.7%	-46.2%
% from 52W Low	57.7%	27.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-2.3%	-20.4%
Earnings Yield (TTM)	-3.4%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MNPR research	View ZURA research